The HIV Care Continuum in Small Cities of Southern New England: Perspectives of People Living with HIV/AIDS, Public Health Experts, and HIV Service Providers.
Anti-HIV Agents
/ therapeutic use
Cities
Continuity of Patient Care
/ organization & administration
Female
HIV Infections
/ drug therapy
Health Knowledge, Attitudes, Practice
Health Personnel
Health Services Accessibility
Humans
Interviews as Topic
Male
New England
/ epidemiology
Patient Acceptance of Health Care
/ statistics & numerical data
Public Health
Qualitative Research
Religion
Social Stigma
Social Support
Socioeconomic Factors
Spirituality
HIV care continuum
HIV treatment cascade
HIV/AIDS
Religiosity/spirituality
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
accepted:
22
09
2020
pubmed:
2
10
2020
medline:
5
3
2021
entrez:
1
10
2020
Statut:
ppublish
Résumé
The HIV care continuum (HCC), comprised of five steps (screening, linkage to care, treatment initiation, retention, and viral suppression), is used to monitor treatment delivery to people living with HIV (PLWH). The HCC has primarily focused on large urban or metropolitan areas where the situation may differ from that in smaller cities. Three themes (i.e., knowledge, stigma, stability) that shaped HCC outcomes were identified from analysis of two qualitative studies involving HIV service providers, public health experts, and PLWH in smaller cities of southern New England. The findings suggest that enhancing HCC outcomes require a multiprong approach that targets both the individual and organizational levels and includes interventions to increase health literacy, staff communication skills, universal screening to assess patients' religiosity/spirituality and supplemental service needs. Interventions that further ensure patient confidentiality and the co-location and coordination of HIV and other healthcare services are particularly important in smaller cities. El cuidado continuo de VIH (HCC), constado de cinco etapas (pruebas, vinculación al cuidado, inico del tratamiento, retención, y supresión viral), se emplea para monitorizar la entrega de tratamientos a las personas que vivien con VIH (PLWH). El HCC ha enfocado principalmente en áreas grandes y urbanas o áreas metropolitanas, donde la situación podría ser diferente que la de las ciudades más pequeñas. Tres temas (i.e., conocimiento, estigma, estabilidad) que formaron los resultados de HCC fueron identificados con análisis de dos estudios cualitativos que involucraron los proveedores de servicios de VIH, expertos de la salud pública, y PLWH en ciudades más pequeñas en las partes sureñas de Nueva Inglaterra. Los hallazgos sugieren que la mejora de los resultados de HCC requiere un enfoque multidimensional que se dirigen a ambos niveles del individuo y organización, y que incluyen intervenciones para aumentar la alfabetización sanitaria, la habilidad de comunicación del personal, la prueba universal para evaluar la religiosidad/espiritualidad de los pacientes y la necesidad de servicios suplementarios. Intervenciones que aseguran aún más la confidencialidad de los pacientes y el co-ubicación y coordinación de los servicios de VIH y otras asistencias medicas son particularmente importantes en ciudades pequeñas.
Autres résumés
Type: Publisher
(spa)
El cuidado continuo de VIH (HCC), constado de cinco etapas (pruebas, vinculación al cuidado, inico del tratamiento, retención, y supresión viral), se emplea para monitorizar la entrega de tratamientos a las personas que vivien con VIH (PLWH). El HCC ha enfocado principalmente en áreas grandes y urbanas o áreas metropolitanas, donde la situación podría ser diferente que la de las ciudades más pequeñas. Tres temas (i.e., conocimiento, estigma, estabilidad) que formaron los resultados de HCC fueron identificados con análisis de dos estudios cualitativos que involucraron los proveedores de servicios de VIH, expertos de la salud pública, y PLWH en ciudades más pequeñas en las partes sureñas de Nueva Inglaterra. Los hallazgos sugieren que la mejora de los resultados de HCC requiere un enfoque multidimensional que se dirigen a ambos niveles del individuo y organización, y que incluyen intervenciones para aumentar la alfabetización sanitaria, la habilidad de comunicación del personal, la prueba universal para evaluar la religiosidad/espiritualidad de los pacientes y la necesidad de servicios suplementarios. Intervenciones que aseguran aún más la confidencialidad de los pacientes y el co-ubicación y coordinación de los servicios de VIH y otras asistencias medicas son particularmente importantes en ciudades pequeñas.
Identifiants
pubmed: 33001353
doi: 10.1007/s10461-020-03049-z
pii: 10.1007/s10461-020-03049-z
pmc: PMC7887013
mid: NIHMS1645824
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
897-907Subventions
Organisme : NIMH NIH HHS
ID : P30 MH062294
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIMH NIH HHS
ID : 5P30MH062294
Pays : United States
Références
UNAIDS. 90–90–90: An ambitious treatment target to help end the AIDS epidemic. 2014. https://www.unaids.org/en/resources/909090 . Accessed 16 Mar 2020.
UNAIDS. 2025 Target setting and 2020–2030 resource needs and impact estimation. 2020. https://unaids.org/en/topics/2025_target_setting . Accessed 15 Mar 2020.
Centers for Disease Control and Prevention. HIV Care Continuum. https: www.hiv.gov/federal-response/policies-issues/hiv-aids-care-continuum . Accessed 1 July 2020.
Connecticut Department of Public Health. HIV continuum of care, Connecticut, 2018. 2018. https://portal.ct.gov/-/media/Departments-and-Agencies/DPH/AIDS--Chronic-Diseases/Surveillance/statewide/graph_hiv_continuum_care.pdf?la=en . Accessed 15 Mar 2020.
Massachusetts Department of Public Health. 2018 Massacusetts HIV/AIDS epidemiologic profile. The Massachusetts HIV care continuum. 2018. https://www.mass.gov/lists/hivaids-epidemiologic-profiles Accessed 15 Mar 2020.
Rhode Island Department of Health. HIV, sexually transmitted diseases, viral hepatitis, and tuberculosis surveillance report, 2018. 2018. https://health.ri.gov/publications/surveillance/2018/HIVSTD.pdf . Accessed 15 Mar 2020.
Burnett JC, Broz D, Spiller MW, Wejnert C, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs—20 cities, United States, 2012. MMWR Morbid Mortal Wkly Rep. 2015;67(1):23–8.
Freeman R, Gwadz MV, Silverman E, et al. Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration. Int J Equity Health. 2017;16:54.
pubmed: 28340589
pmcid: 5364619
Risher K, Mayer K, Beyrer C. The HIV treatment cascade in men who have sex with men, people who inject drugs and sex workers. Curr Opin HIV AIDS. 2015;10(6):420–9.
pubmed: 26352393
pmcid: 4880053
Cha AE, Cohen RA. QuickStats: percentage of adults aged ≥18 years who did not take their medication as prescribed or asked for lower-cost medication to save money among those prescribed medication in the past 12 months, by number of chronic conditions — National Health Interview Survey, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:990.
Davtyan M, Olshansky EF, Brown B, Lakon C. A grounded theory study of HIV-related stigma in U.S.-based care settings. J Assoc Nurse AIDS Care. 2017;28(6):907–22.
Earnshaw VA, Reed NM, Watson RJ, Maksut JL, Allen AM, Eaton LA. Intersectional internalized stigma among Black gay and bisexual men: a longitudinal analsyis spanning HIV/sexually transmitted infection diagnosis. J Health Psychol. 2019;28(8):1083–9.
Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV Stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–95.
pubmed: 23456594
pmcid: 3664141
Bauman LJ, Braunstein S, Calderon Y, et al. Barriers and facilitators of linkage to HIV primary care in New York City. J Acquir Immune Defic Syndr. 2013;64(Suppl 1):S20–26.
pubmed: 24126445
pmcid: 3888646
Beattie CM, Wiewel EW, Zhong Y, et al. Multilevel factors associated with a lack of viral suppression among person living with HIV in a Federally funded housing program. AIDS Behav. 2019;23(3):784–91.
pubmed: 30680539
Colasanti J, Stahl N, Farber EW, del Rio C, Armstrong WS. An exploratory study to assess individual and structural level barriers associated with poor retention and re-engagement in care among person living with HIV/AIDS. J Acquir Immune Defic Syndr. 2017;74(Supp 2):S113–120.
pubmed: 28079721
pmcid: 6140317
Nelson JA, Kinder A, Johnson AS, et al. Differences in selected HIV care continuum outcomes among people residing in rural, urban, and metropolitan areas—28 US jurisdictions. J Rural Health. 2018;34(1):63–70.
pubmed: 27620836
Diepstra KL, Cunningham T, Rhodes AG, Yerkes LE, Buyu CA. Prevalence and predictors of provider-initiated offers among heterosexual persons at increased risk for acquiring HIV infection – Virginia, 2016. MMWR Morbid Mortal Wkly Rep. 2018;67(25):714–7.
Pitasi MA, Delaney KP, Brooks JT, DiNenno EA, Johnson SD, Prejean J. HIV testing in 50 local jurisdictions accounting for the majority of new HIV diagnoses and seven states with disproportionate occurrence of HIV in rural areas, 2016–2017. MMWR Morb Mortal Wkly Rep. 2019;68:561–7.
pubmed: 31246940
pmcid: 6597119
Henderson ER, Subramaniam DS, Chen J. Rural-urban differences in human immunodeficiency virus testing among US adults: findings from the behavioral risk factor surveillance survey. Sex Transm Dis. 2018;45(12):808–12.
pubmed: 29965946
Messer LC, Quinlivan EB, Parnell H, et al. Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color. AIDS Patient Care STDs. 2013;27(7):398–407.
pubmed: 23829330
pmcid: 3704120
Mgbere O, Khuwaja S, Bell TK, et al. Managing the personal side of health care among patients with HIV/AIDS: a pilot study of providers’ perspectives. J Int Assoc Provid AIDS Care. 2017;16(2):149–60.
pubmed: 25331218
Sutherland JL, Spencer GA. HIV screening intentions, behaviors, and practices among nurse practitioners. J Am Assoc Nurse Pract. 2017;29:264–71.
pubmed: 27860463
Sutherland JL, Spencer GAUS. nurse practitioner beliefs about routine HIV screening: predicting behaviors. J Assoc Nurses AIDS Care. 2019;30(3):270–8.
pubmed: 30601203
Grau LE, Griffiths-Kundishora A, Heimer R, et al. Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV/AIDS: perspectives of HIV surveillance experts and service providers. Addict Sci Clin Pract. 2017;12:24.
pubmed: 28965489
pmcid: 5623965
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
doi: 10.1191/1478088706qp063oa
Braun V, Clarke V. Successful qualitative research: a practical guide for beginners. Thousand Oaks: SAGE Publications Ltd; 2013.
Henwood K, Pidgeon NF. Qualitative research and psychological theorizing. Br J Psychol. 1992;83(1):97–111.
pubmed: 1559146
Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.
pubmed: 16846321
Hargreaves JR, Delany-Moretlwe S, Hallett TB, et al. The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. Lancet HIV. 2016;3(7):e318–322.
pubmed: 27365206
Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–83.
pubmed: 3378902
Barroso J, Leblanc NM, Flores D. It’s not just the pills: a qualitative meta-synthesis of HIV antiretroviral adherence research. J Assoc Nurses AIDS Care. 2017;28(4):462–78.
pubmed: 28286006
Maslow AH. Motivation and personality. New York: Harper and Row; 1970.
Rochon D, Ross MW, Looney C, Nepal VP, Price AJ, Giordano TP. Communication strategies to improve HIV treatment adherence. Health Commun. 2011;26:461–7.
pubmed: 21432703
Taylor BS, Fornos L, Tarbutton J, et al. Improving HIV care engagement in the South for the patient and provider perspective: the role of stigma, social support, and shared decision-making. AIDS Patient Care STDs. 2018;32(9):368–78.
pubmed: 30179530
pmcid: 6121178
Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum engagement in HIV care: an important predictor of long-term retention in care and viral suppression. Clin Infect Dis. 2015;61:1880–7.
pubmed: 26265499
Rana AI, Gillani FS, Flanigan TP, Nash BT, Beckwith CG. Follow-up care among HIV-infected pregnant women in Mississippi. J Womens Health. 2010;19:1863–7.
Swain CA, Smith LC, Nash D, et al. Postpartum loss to HIV care and HIV viral suppression among previously diagnosed HIV-infected women with a live birth in New York State. PLoS ONE. 2016;11:e0160775.
pubmed: 27513953
pmcid: 4981467
Anderson EA, Momplaisir FM, Corson C, Brady KA. Assessing the impact of perinatal HIV case management on outcomes along the HIV care continuum for pregnant and postpartum women living with HIV, Philadelphia 2005–2013. AIDS Behav. 2017;21:2670–81.
pubmed: 28176167
Momplaisir FM, Storm DS, Nkwohoreze H, Jayeola O, Jemmott JB. Improving postpartum retention in care for women living with HIV in the United States. AIDS. 2018;32:133–42.
pubmed: 29194122
pmcid: 5757672
Pinto RM, Witte SS, Filippone PL, Baird KL, Whitman WR. Factors that influence linkages to HIV continuum of care services: implications for multi-level interventions. Int J Environ Res Public Health. 2017;14:1355–66.
pmcid: 5707994
Dalmida SG, McCoy K, Koenig HG, et al. Examination of the role of religious and psychosocial factors in HIV medication adherence rates. J Relig Health. 2017;56:2144–61.
pubmed: 28285439
Doolittle BR, Justice AC, Fiellin DA. Religion, spirituality, and HIV clinical outcomes: a systematice review of the literature. AIDS Behav. 2018;22(6):1792–801.
pubmed: 28004218
Fincchario-Kessler S, Catley D, Berkley-Patton J, et al. Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs. AIDS Patient Care STDs. 2011;25(2):103–11.
Kendrick HM. Are religion and spirituality barriers or facilitators to treatment for HIV: a systematic review of the literature. AIDS Care. 2017;29(1):1–13.
Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13:1160–77.
pubmed: 19636699
pmcid: 4511707
Turan B, Budhwani H, Fazeli PL, et al. How does stigma affect people living with HIV? The mediating roles of internalized and anticipated HIV stigma in the effects of perceived community stigma on health and psychosocial outcomes. AIDS Behav. 2017;21(1):283–91.
pubmed: 27272742
pmcid: 5143223
Eaton LA, Earnshaw VA, Maksut JL, Thorson KR, Watson RJ, Baumeister JA. Experience of stigma and health care engagement among Black MSM newly diagnosed with HIV/STI. J Behav Med. 2018;41:458–66.
pubmed: 29626312
pmcid: 6031458
Rice WS, Turan B, Fletcher FE, et al. A mixed methods study of anticipated and experienced stigma in health care settings among women living with HIV in the United States. AIDS Patient Care STDs. 2019;33(4):184–95.
pubmed: 30932700
pmcid: 6459270
Dang BN, Westbrook RA, Njue SM, Giordano TP. Building trust and rapport early in the new doctor-patient relationship: a longitudinal qualitative study. BMC Med Educ. 2017;17(1):32.
pubmed: 28148254
pmcid: 5288896
Dang B, Westbrook R, Hartman C, Giordano T. Retaining patients in care: the role of initial patient care experiences. AIDS Behav. 2016;20(10):2477–87.
pubmed: 26910339
pmcid: 4996755
Castel AD, Tang W, Peterson J, et al. Sorting through the lost and found: are patient perceptions of engagement in care consistent with standard continuum of care measures? J Acquir Immune Defic Syndr. 2015;69(S1):S44–55.
pubmed: 25867778
pmcid: 4480343
Risher K, Mayer KH, Beyrer C. HIV treatment cascade in MSM, people who inject drugs, and sex workers. Curr Opin HIV AIDS. 2015;10(6):420–9.
pubmed: 26352393
pmcid: 4880053